Matthew Whalen
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Mr. Matthew P.
Whalen, CPA, is an Independent Director at MIRA Pharmaceuticals, Inc., an Independent Director at Telomir Pharmaceuticals, Inc. and a Chief Financial Officer at Power Digital Marketing, Inc. He is on the Board of Directors at MIRA Pharmaceuticals, Inc. and Telomir Pharmaceuticals, Inc. Mr. Whalen was previously employed as a Chief Financial Officer by MRC Smart Technology Solutions, Inc. He received his undergraduate degree from the University of San Diego.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 | |
| 21.07.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.08.2024 |
| MIRA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 18.11.2024 |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Finanzdirektor/CFO | - |
| Unternehmen | Position | Ende |
|---|---|---|
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Finanzdirektor/CFO | 01.05.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of San Diego
University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Power Digital Marketing, Inc.
Power Digital Marketing, Inc. Advertising/Marketing ServicesCommercial Services Operates as a digital marketing agency | Commercial Services |
MRC Smart Technology Solutions, Inc.
MRC Smart Technology Solutions, Inc. Commercial Printing/FormsCommercial Services Provides printing services | Commercial Services |
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen